Duchenne muscular dystrophy (Duchenne), today announced a grant to Nemours/Alfred I. duPont Hospital for Children in Wilmington, Delaware, allowing Dr. Mena Scavina, director of the hospital s muscle clinic, to spend dedicated time working as an advisor to the PPMD team. As part of this new role, Dr. Scavina will develop and optimize a variety of programs within PPMD s portfolio to advance clinical care to all people living with or affected by Duchenne.
Nemours was named a Certified Duchenne Care Center (CDCC) by PPMD in August 2017, and is one of 28 certified centers throughout the United States. Through the certification program, PPMD established an ongoing and collaborative relationship with Dr. Scavina, the center s neuromuscular program director.
Delaware Business Now
Reading Time: 2 minutes
Bayhealth and Nemours Children’s Health System formally opened the new Nemours Building at 101 Wellness Way, on the Bayhealth Sussex Campus, Milford.
The center expands pediatric care to families in Kent and Sussex counties. The new three-story, medical office building is located across the street from the hospital and outpatient center.
“As a nurse and a mom I know how important it is to have the best level of care accessible to our children when they need it. The collaboration between Nemours and Bayhealth will provide access to world class healthcare for our families,” said Delaware Lt. Governor Bethany Hall-Long, who attended and spoke at a recent ribbon cutting ceremony.
E-Mail
IMAGE: A preclinical study shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues. This technology, using. view more
Credit: MD Anderson Cancer Center
Abstract #LB008
HOUSTON A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues. This technology, using precision therapy targeting of cell-surface proteins through a Bicycle toxin conjugate (BTC), shows encouraging results for the treatment of osteosarcoma.
Alithya Implements Oracle Human Capital Management Cloud for Nemours Children s Health System
News provided by
Share this article
Share this article
ALPHARETTA, Ga., April 8, 2021 /PRNewswire/ - Alithya Group inc. (NASDAQ: ALYA) (TSX: ALYA) ( Alithya ), a leader in strategy and digital transformation employing more than 3,000 highly-qualified professionals and offering enterprise solutions throughout the United States, Canada, and Europe, has successfully implemented Oracle Human Capital Management (Oracle HCM) Cloud for Nemours Children s Health System to support its core human resource management, employee and manager self-service, recruiting, onboarding, and analytics reporting. Nemours has also deployed Oracle HR Help Desk Cloud as part of this implementation.
Child with brain injuries making progress, family says. Mom charged with abuse remains jailed.
Updated Apr 06, 2021;
A 4-year-old South Jersey girl who was hospitalized with brain injuries in February is showing signs of improvement, a family member said.
While it seems the girl will have some level of permanent brain damage, she continues to make progress, according to her great-aunt, Anita Simms-Doughty.
She isn’t been able to talk yet, but recognizes family members.
“She’s awake and alert. She knows that everybody is around,” Simms-Doughty said.
Muniz and her boyfriend brought the child to Inspira Medical Center Mullica Hill on Feb. 24, where doctors found multiple injuries, including bleeding on the brain and damage to her chest, authorities have said.